# Development of a Pharmacogenomic Panel for Early Detection of Chemotherapy- and Immunotherapy-Induced Cardiotoxicity.

> **NCT07663357** · — · RECRUITING · sponsor: **Beneficência Portuguesa de São Paulo** · enrollment: 1000 (estimated)

## Conditions studied

- Cardiotoxicity

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT07663357
- **Lead sponsor:** Beneficência Portuguesa de São Paulo
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2026-05-11
- **Primary completion:** 2029-03-01
- **Final completion:** 2029-12-30
- **Target enrollment:** 1000 (ESTIMATED)
- **Last updated:** 2026-06-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07663357

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07663357, "Development of a Pharmacogenomic Panel for Early Detection of Chemotherapy- and Immunotherapy-Induced Cardiotoxicity.". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07663357. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*